Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_665a1ccbeb11cc1bcdd3c4d078d4e3f0 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1709 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-12 |
filingDate |
2012-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cc375579e4bf6156d7a802b64da1c001 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_981026cbcea7de3657158548e1b34c4c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5f42f557b007cc8fdca37b40317b40e6 |
publicationDate |
2014-06-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
KR-20140071565-A |
titleOfInvention |
Oral vaccine supplement including human cathelicidin LL-37 |
abstract |
The present invention relates to an oral vaccine composition comprising an oral vaccine adjuvant comprising human cathelicidin LL-37, an oral vaccine conjugated with an antigen and human catecholizidine LL-37, and a method of stimulating a human immune response using the oral vaccine will be. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20200132474-A |
priorityDate |
2012-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |